Dr. Veeral Ajmera is Associate Professor of Medicine in the Division of Gastroenterology and Hepatology and Medical Director of Liver Transplantation at the University of California, San Diego. Dr. Ajmera serves as an investigator in the UCSD Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Research Unit where his research focuses on non-invasive biomarkers, genetics and patient factors associated with disease severity and prognosis.

Matthew Kappus, MD is the medical director for the living donation liver transplant and combined heart-liver transplant programs at Duke University Hospital. He conducts research in understanding physical function and transplant optimization for those undergoing liver transplantation.

Doug Simonetto is a Transplant Hepatology and Associate Professor of Medicine at Mayo Clinic, Rochester. He serves as the Director of the Gastroenterology and Hepatology Fellowship Program and Co-Director of Data Analytics and Artificial Intelligence Laboratory. His research focuses on portal hypertension and alcohol-associated liver disease.

Karn Wijarnpreecha, M.D., M.P.H., is a Transplant Hepatologist at Mayo Clinic in Jacksonville, Florida. He previously served as Associate Professor of Medicine and Director of Clinical Research in the Division of Gastroenterology and Hepatology at the University of Arizona College of Medicine–Phoenix and Banner University Medical Center Phoenix. He is board-certified in internal medicine, gastroenterology, transplant hepatology, and obesity medicine.

.

I am an Associate Professor of Medicine at Virginia Commonwealth University and serve as faculty for the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health. My areas of interest are clinical trials, biomarker development and steatohepatitis from both alcohol and the Metabolic syndrome.

Rena K. Fox, MD, FACP is Professor of Clinical Medicine at the University of California, San Francisco (UCSF) and an internationally recognized investigator whose work has advanced the integration of hepatology into primary care. Her research spans viral hepatitis, MASLD/MASH, cirrhosis, and hepatocellular carcinoma, with a particular emphasis on implementation science and population health approaches to liver disease.

Dr. Meagan Gray is as Associate Professor of Medicine at the University of Alabama at Birmingham. She founded and directs the MASLD clinic and is the Program Director for the Transplant Hepatology Fellowship Program. Her interests lie in obesity, nutrition, and healthcare disparities for patients living with MASLD.

Dr. Saroja Bangaru is a transplant hepatologist and Assistant Professor of Medicine in the Division of Gastrointestinal and Liver Diseases at Keck School of Medicine at the University of Southern California. She has dedicated time at Los Angeles General Hospital where she takes care of patients and is working on expanding specialty care for liver patients within the safety net healthcare system. She is interested in implementation science and utilizing principles of implementation science to expand guideline-concordant care within the safety net hospital.

Dr. Brown is a professor of Medicine at Wayne State University and Michigan State University. She is the past Medical Director of Liver Transplantation and Chief of the Division of Gastroenterology and Hepatology at Henry Ford Health. She is currently the Medical Director of Transplant Outreach Services and Associate Medical Director of the Henry Ford Transplant Institute. She is the current Chair of the AASLD Foundation Board and past Secretary of AASLD.